Search Grant Opportunities

Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)

ID: RFA-DK-25-005 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

Posted: April 29, 2024, 12:00 a.m. EDT
The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the Type 1 Diabetes TrialNet Clinical Network Hub (HUB), a screening and clinical activities coordination unit for clinical trials focusing on the prevention of and early intervention in type 1 diabetes (T1D). The main objective of the HUB is to increase the efficiency and productivity of the TrialNet network by providing coordination of communications and outreach and developing new tools and approaches to increase screening, recruitment and retention. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.
Posted: Dec. 21, 2023, 12:00 a.m. EST
Posted: Dec. 21, 2023, 12:00 a.m. EST
Background
The Type 1 Diabetes TrialNet Clinical Network Hub (HUB) is a screening and clinical activities coordination unit for clinical trials focusing on the prevention of and early intervention in type 1 diabetes (T1D). The main objective of the HUB is to increase the efficiency and productivity of the TrialNet network by providing coordination of communications and outreach and developing new tools and approaches to increase screening, recruitment, and retention.

Grant Details
The HUB is responsible for enhancing risk screening, trial recruitment outreach, supporting clinical trial and ancillary studies operations, enhancing administration/leadership, organizing future goals, and executing excellent communication and coordination. The HUB will also work on increasing diversity among TrialNet participants. The HUB will participate in the oversight of clinical aspects related to the development and implementation of trials over the funding period.

Eligibility Requirements
The Program Director/Principal Investigator (PD/PI) must be a physician and clinical trialist with an extensive track record for recruiting and enrolling individuals into multi-center clinical trials in T1D prevention. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, state governments, county governments, city or township governments, special district governments, Indian/Native American Tribal Governments (Federally Recognized), U.S. Territory or Possession, independent school districts, public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), faith-based or community-based organizations.

Period of Performance
The project period is 5 years starting from October 17, 2024. The application budget is limited to approximately $750,000 per year in direct costs.

Grant Value
$1,000,000 is intended to be committed in FY 2025 to fund 1 award. The award budget for all years may vary based on available funds and network activity.

Overview

Category of Funding
Food and Nutrition
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 4/29/24 the National Institutes of Health posted grant opportunity RFA-DK-25-005 for Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed). The grant will be issued under grant program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.

Timing

Posted Date
April 29, 2024, 12:00 a.m. EDT
Closing Date
Oct. 17, 2024, 12:00 a.m. EDT Past Due
Last Updated
May 1, 2024, 9:33 a.m. EDT
Version
1
Archive Date
Nov. 22, 2024

Eligibility

Eligible Applicants
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
Special district governments
Independent school districts
County governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Small businesses
City or township governments
Public and State controlled institutions of higher education
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-005.html

Documents

Posted documents for RFA-DK-25-005

Grant Awards

Grants awarded through RFA-DK-25-005

Incumbent or Similar Grants

Grants similar to RFA-DK-25-005

Similar Active Opportunities

Open grant opportunities similar to RFA-DK-25-005

Experts for Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire